📋 LENZ THERAPEUTICS, INC. (GRPH) - Financial Results
Filing Date: 2026-01-07
Accepted: 2026-01-07 17:10:10
Event Type: Financial Results
Event Details:
Graphite Bio Inc (was merged with LENZ Therapeutics on 15/11/2023) (GRPH) Reports Q1 2026 Financial Results
Graphite Bio Inc (was merged with LENZ Therapeutics on 15/11/2023) (GRPH) announced its financial results for the period ending Q1 2026.
Key Financial Highlights:
Revenue: $1
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: Not disclosed
📊 Key Financial Metrics:
Metric
Value
Revenue
$1
💼 Business Developments:
Partnership
Acquisition: Not available
Licensing
Regulatory Approval
Executive Changes: Not available
Structured Data:
Company Name: Graphite Bio Inc (was merged with LENZ Therapeutics on 15/11/2023)
📋 LENZ THERAPEUTICS, INC. (GRPH) - Financial Results
Filing Date: 2026-01-07
Accepted: 2026-01-07 17:10:10
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: